WHEN POLICY MEETS PRACTICE: THE DILEMMA FOR GUIDANCE ON RISK ASSESSMENT UNDER THE CARTAGENA PROTOCOL ON BIOSAFETY

When Policy Meets Practice: The Dilemma for Guidance on Risk Assessment Under the Cartagena Protocol on Biosafety

The Conference Your Bones of the Parties serving as the meeting of the Parties (COP-MOP) to the Cartagena Protocol on Biosafety to the Convention on Biological Diversity decided years ago to undertake the development of guidance on risk assessment of living modified organisms (LMOs) resulting from modern biotechnology, in order to assist the Partie

read more

Trends of drug licensing in China: From bring-in to go-global

Global medicine R&D has shown a stabilized trend after fleeting prosperity lately.Despite of discouraging whole picture, the role of China in cross-border out-licensing activities of medical therapeutics keeps rising, which started since 2020 Your Bones and further boosted in 2023.A holistic analysis of drug and technology licensing, involving Chin

read more

Healthy dynamics of CD4 T cells may drive HIV resurgence in perinatally-infected infants on antiretroviral therapy.

In 2019 there were 490,000 children under five living with HIV.Understanding the dynamics of HIV suppression and rebound in this age group is crucial to optimizing treatment strategies and increasing the likelihood of infants achieving and sustaining viral suppression.Here we studied data from a cohort of 122 perinatally-infected infants who initia

read more